The new criterion for FPG will identify many more individuals who are at risk for developing diabetes.
The FDA has approved the first of a new class of antibiotics for the treatment of complicated skin and skin structure infections. Daptomycin is a cyclic lipopeptide that is active against Gram-positive bacteria.
St Johns Wort and Drug Interactions; Serum Potassium and Stroke Risk Among Hypertensive Adults; Skin Cancer Prevention and Detection Practices Among Siblings of Patients with Melanoma
To improve patient survival, the emergency physician (EP) must be knowledgeable about current concepts and controversies in the management of patients in shock. No longer can one simply rely on the presence of traditional clinical markers of shock to make the diagnosis. New and innovative monitoring techniques, as well as continually evolving treatment algorithms, are at the forefront of shock research. This article will educate and update the EP on current and future trends in the management of patients in shock. Equipped with this information, the EP more effectively can identify patients in shock, administer the latest evidence-based treatment, and ultimately improve patient outcome.
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
In this report, Higgins and colleagues report on a multicenter trial on the efficacy of cardiac resynchronization therapy in patients with an indication for an implantable cardioverter defibrillator.
In this study, Blackshear and colleagues report on their experience with thoracoscopic surgical techniques to close the left atrial appendage as prophylaxis against stroke in patients with atrial fibrillation.
